Peripheral but Not Central Glucagon-Like Peptide-1 Receptor Agonism Regulates Fasting Dyslipidemia by Reducing VLDL Production

被引：0
|
作者：
Taher, Jennifer
Baker, Chris
Cuizon, Carmelle
Naples, Mark
Farr, Sarah
Adeli, Khosrow
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A438
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity
    Golubic, Rajna
    Kennet, Jane
    Parker, Victoria
    Robertson, Darren
    Luo, Dan
    Hansen, Lars
    Jermutus, Lutz
    Ambery, Phil
    Ryaboshapkina, Maria
    Surakala, Manasa
    Laker, Rhianna C.
    Venables, Michelle
    Koulman, Albert
    Park, Adrian
    Evans, Mark
    DIABETES OBESITY & METABOLISM, 2024, 26 (07): : 2634 - 2644
  • [32] Control of human pancreatic beta cell kinome by glucagon-like peptide-1 receptor biased agonism
    Xiao, Jiannan
    El Eid, Liliane
    Buenaventura, Teresa
    Boutry, Raphael
    Bonnefond, Amelie
    Jones, Ben
    Rutter, Guy A.
    Froguel, Philippe
    Tomas, Alejandra
    DIABETES OBESITY & METABOLISM, 2023, 25 (08): : 2105 - 2119
  • [33] Can epicardial fat glucagon-like peptide-1 receptor open up to the cardiovascular benefits of glucagon-like peptide-1 analogues?
    Iacobellis, Gianluca
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (03): : 224 - 225
  • [34] Association of fasting glucagon-like peptide-1 and glucose dependent insulinotropic polypeptide with dyslipidemia in newly diagnosed diabetes
    Waris, Nazish
    Bano, Samina
    Fawwad, Asher
    Basit, Abdul
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2023, 43 (01) : 91 - 98
  • [35] Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis
    Linnemann, Amelia K.
    Neuman, Joshua C.
    Battiola, Therese J.
    Wisinski, Jaclyn A.
    Kimple, Michelle E.
    Davis, Dawn Belt
    MOLECULAR ENDOCRINOLOGY, 2015, 29 (07) : 978 - 987
  • [36] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [37] Association of fasting glucagon-like peptide-1 and glucose dependent insulinotropic polypeptide with dyslipidemia in newly diagnosed diabetes
    Nazish Waris
    Samina Bano
    Asher Fawwad
    Abdul Basit
    International Journal of Diabetes in Developing Countries, 2023, 43 : 91 - 98
  • [38] Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation
    Punjabi, Mukesh
    Arnold, Myrtha
    Geary, Nori
    Langhans, Wolfgang
    Pacheco-Lopez, Gustavo
    PHYSIOLOGY & BEHAVIOR, 2011, 105 (01) : 71 - 76
  • [39] Glucagon-like peptide-1 and satiety
    S. R. Bloom
    Nature, 1997, 385 : 214 - 214
  • [40] A role for glucagon-like peptide-1 in the central regulation of feeding
    Turton, MD
    OShea, D
    Gunn, I
    Beak, SA
    Edwards, CMB
    Meeran, K
    Choi, SJ
    Taylor, GM
    Heath, MM
    Lambert, PD
    Wilding, JPH
    Smith, DM
    Ghatei, MA
    Herbert, J
    Bloom, SR
    NATURE, 1996, 379 (6560) : 69 - 72
12345